Business
UPDATE - Dewmar International BMC, Inc. Takes Steps to Secure Intellectual Property Related to Cannabinoids and the Treatment of Post-Traumatic Stress Disorder
UPDATE - Dewmar International BMC, Inc. Takes Steps to Secure Intellectual Property Related to Cannabinoids and the Treatment of Post-Traumatic Stress Disorder.
About this update from Dewmar Intl Bmc Inc
[{"type":"text","content":"\n \n \n UPDATE - Dewmar International BMC, Inc. Takes Steps to Secure Intellectual Property Related to Cannabinoids and the Treatment of Post-Traumatic Stress Disorder\n \n \nUPDATE - Dewmar International BMC, Inc. Takes Steps to Secure Intellectual Property Related to Cannabinoids and the Treatment of Post-Traumatic Stress Disorder\n\nDewmar to Pursue Licensing Strategy for Platform Technology Related to Delivery of Cannabinoids\n\n \n NEW ORLEANS, LA--(Marketwired - Aug 9, 2017) - Dewmar International BMC, Inc. (the \"Company\") (OTC PINK: DEWM) today announced that it has filed documents with the United States Patent and Trademark Office for the treatment of Post-Traumatic Stress Disorder (PTSD) using cannabinoids. \n Post-Traumatic Stress Disorder (PTSD) is a growing problem in the United States that is poised to reach epidemic proportions over the near future. PTSD currently affects about 7 million Americans. PTSD can occur at any age and is usually accompanied by symptoms such as depression, anxiety, insomnia, substance abuse, and other anxiety disorders. \n Years of war in Afghanistan and Iraq have brought post-traumatic stress disorder among military personnel to the immediate attention of the general public. The United States Department of Veterans Affairs estimates that over 30% of all Vietnam veterans have PTSD and 10% of all Gulf War veterans have PTSD. This growing disease also affects 11% of all veterans of the war in Afghanistan and 20% of Iraqi War veterans. Although PTSD has recently just garnered attention, it is a serious problem that can affect non-military people. \n Dr. Donisha Dunn-Lombard, M.D., a Clinical Psychiatrist from New Orleans, Louisiana and a member of Dewmar International's Medical Advisory Board commented, \"Some people may associate the term post-traumatic stress disorder (PTSD) with combat veterans but actually PTSD can affect any one who has experienced or witnessed a traumatic event such as an assault, natural disaster, or car accident. Someone suffering from PTSD can have significant impairment in their functioning at work, at home, and in personal relationships.\"\n Dewmar is creating an extensive portfolio of intellectual property related to cannabinoids and innovative delivery systems of these cannabinoids (CBDs) to treat people afflicted with lung disease, Parkinson's Disease and PTS...